Outcomes of Antiretroviral Therapy in the Swiss HIV Cohort Study: Latent Class Analysis

被引:0
|
作者
Olivia Keiser
Ben Spycher
Andri Rauch
Alexandra Calmy
Matthias Cavassini
Tracy R. Glass
Dunja Nicca
Bruno Ledergerber
Matthias Egger
机构
[1] University of Bern,Institute of Social and Preventive Medicine (ISPM)
[2] Bern University Hospital and University of Bern,University Clinic for Infectious Diseases
[3] University Hospital Geneva,Division of Infectious Diseases
[4] University Hospital Lausanne,Division of Infectious Diseases
[5] University Hospital Basel,Basel Institute for Clinical Epidemiology and Biostatistics
[6] Cantonal Hospital St.Gallen,Division of Infectious Diseases
[7] University Hospital,Division of Infectious Diseases and Hospital Epidemiology
[8] University of Zürich,undefined
来源
AIDS and Behavior | 2012年 / 16卷
关键词
HIV infection; Antiretroviral therapy; Disease progression; Mortality; Social factors; Behavior; Latent class analysis;
D O I
暂无
中图分类号
学科分类号
摘要
An in-depth understanding of the different groups that make up the HIV-infected population should inform prevention and care. Using latent class analysis (LCA) we identified seven groups with similar socio-demographic and behavioral characteristics at enrolment in the Swiss HIV Cohort Study: older gay men, younger gay men, older heterosexual men, injection drug users, single migrants, migrant women in partnerships and heterosexual men and women. Outcomes of combination antiretroviral therapy (ART) were analyzed in 1,633 patients starting ART. Compared to older gay men, the probability of a virologic response to ART was reduced in single migrants, in older heterosexual men and in IDUs. Loss to follow-up was higher in single migrants and IDUs, and mortality was increased in older heterosexual men and IDUs. Socio-behavioral groups identified by LCA allow insights above what can be gleaned from traditional transmission groups, and may identify patients who could benefit from targeted interventions.
引用
收藏
页码:245 / 255
页数:10
相关论文
共 50 条
  • [21] Antiretroviral Therapy in Relation to Birth Outcomes among HIV-infected Women: A Cohort Study
    Li, Nan
    Sando, Mary Mwanyika
    Spiegelman, Donna
    Hertzmark, Ellen
    Liu, Enju
    Sando, David
    Machumi, Lameck
    Chalamilla, Guerino
    Fawzi, Wafaie
    JOURNAL OF INFECTIOUS DISEASES, 2016, 213 (07): : 1057 - 1064
  • [22] Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study
    Young, J
    De Geest, S
    Spirig, R
    Flepp, M
    Rickenbach, M
    Furrer, H
    Bernasconi, E
    Hirschel, B
    Telenti, A
    Vernazza, P
    Battegay, M
    Bucher, HC
    BRITISH MEDICAL JOURNAL, 2004, 328 (7430): : 15 - 18B
  • [23] Swiss HIV Cohort Study
    不详
    AIDS PATIENT CARE AND STDS, 1999, 13 (06) : 376 - 376
  • [24] Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy - The Swiss HIV Cohort Study
    Friedl, AC
    Ledergerber, B
    Flepp, M
    Hirschel, B
    Telenti, A
    Furrer, H
    Bucher, HC
    Bernasconi, E
    Weber, R
    AIDS, 2001, 15 (14) : 1793 - 1800
  • [25] Emergence of Drug Resistance in the Swiss HIV Cohort Study Under Potent Antiretroviral Therapy Is Observed in Socially Disadvantaged Patients
    Abela, Irene A.
    Scherrer, Alexandra U.
    Boeni, Juerg
    Yerly, Sabine
    Klimkait, Thomas
    Perreau, Matthieu
    Hirsch, Hans H.
    Furrer, Hansjakob
    Calmy, Alexandra
    Schmid, Patrick
    Cavassini, Matthias
    Bernasconi, Enos
    Guenthard, Huldrych F.
    Anagnostopoulos, A.
    Battegay, M.
    Bernasconi, E.
    Boni, J.
    Braun, D. L.
    Bucher, H. C.
    Calmy, A.
    Cavassini, M.
    Ciuffi, A.
    Dollenmaier, G.
    Egger, M.
    Elzi, L.
    Fehr, J.
    Fellay, J.
    Furrer, H.
    Fux, C. A.
    Gunthard, H. F.
    Haerry, D.
    Hasse, B.
    Hirsch, H. H.
    Hoffmann, M.
    Hosli, I
    Huber, M.
    Kahlert, C.
    Kaiser, L.
    Keiser, O.
    Klimkait, T.
    Kouyos, R. D.
    Kovari, H.
    Ledergerber, B.
    Martinetti, G.
    de Tejada, Martinez B.
    Marzolini, C.
    Metzner, K. J.
    Mueller, N.
    Nicca, D.
    Paioni, P.
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (02) : 297 - 303
  • [26] AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy - The Swiss HIV Cohort Study
    Ledergerber, B
    Erard, V
    Weber, R
    Hirschel, B
    Furrer, H
    Battegay, M
    Vernazza, P
    Bernasconi, E
    Opravil, M
    Kaufmann, D
    Sudre, P
    Francioli, P
    Telenti, A
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (23): : 2220 - 2226
  • [27] Hepatitis B Virus Infection Is Associated With Impaired Immunological Recovery During Antiretroviral Therapy in the Swiss HIV Cohort Study
    Wandeler, Gilles
    Gsponer, Thomas
    Bihl, Florian
    Bernasconi, Enos
    Cavassini, Matthias
    Kovari, Helen
    Schmid, Patrick
    Battegay, Manuel
    Calmy, Alexandra
    Egger, Matthias
    Furrer, Hansjakob
    Rauch, Andri
    JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (09): : 1454 - 1458
  • [28] Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study
    Conen, Anna
    Fehr, Jan
    Glass, Tracy R.
    Furrer, Hansjakob
    Weber, Rainer
    Vernazza, Pietro
    Hirschel, Bernard
    Cavassini, Matthias
    Bernasconil, Enos
    Bucher, Heiner C.
    Battegay, Manuel
    ANTIVIRAL THERAPY, 2009, 14 (03) : 349 - 357
  • [29] Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy
    Polesel, Jerry
    Clifford, Gary M.
    Rickenbach, Martin
    Dal Maso, Luigino
    Battegay, Manuel
    Bouchardy, Christine
    Furrer, Hansjakob
    Hasse, Barbara
    Levi, Fabio
    Probst-Hensch, Nicole M.
    Schmid, Patrick
    Franceschi, Silvia
    AIDS, 2008, 22 (02) : 301 - 306
  • [30] Uniform risk of clinical progression despite differences in utilization of highly active antiretroviral therapy: Swiss HIV Cohort Study
    Junghans, C
    Low, N
    Chan, P
    Witschi, A
    Vernazza, P
    Egger, M
    AIDS, 1999, 13 (18) : 2547 - 2554